2019
DOI: 10.1590/0047-2085000000225
|View full text |Cite
|
Sign up to set email alerts
|

What happens after an oral ingestion of haloperidol decanoate? – A case report

Abstract: Haloperidol decanoate is a first generation antipsychotic drug used to treat patients with schizophrenic disorder who require prolonged parenteral antipsychotic therapy. Cases of oral haloperidol decanoate are rare, and only one has been reported in foreign literature. In this report, we present a case of an oral ingestion of haloperidol decanoate of a male with schizophrenic disorder who presented to the emergency department following an oral ingestion of 1 ampoule of haloperidol decanoate 100 mg. At presenta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…Documentary study with a quantitative design (PEREIRA et al, 2018) whose primary data sources were medical records of users of psychosocial care center, in Northeastern Brazil.…”
Section: Methodsmentioning
confidence: 99%
“…Documentary study with a quantitative design (PEREIRA et al, 2018) whose primary data sources were medical records of users of psychosocial care center, in Northeastern Brazil.…”
Section: Methodsmentioning
confidence: 99%